David P. Luci - Feb 5, 2025 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Jeffrey Cohan, Power of Attorney For: David P. Luci
Stock symbol
ACXP
Transactions as of
Feb 5, 2025
Transactions value $
$0
Form type
4
Date filed
2/6/2025, 05:46 PM
Previous filing
Jan 8, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Stock Option Award $0 +250K $0.00 250K Feb 5, 2025 Common Stock 250K $0.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 5, 2025, the Reporting Person was granted stock options to purchase 250,000 shares of the Issuer's common stock. These options vest immediately.